Deferred Income Tax Liabilities, Net of ACCENDRA HEALTH INC/VA/ from 31 Dec 2017 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
ACCENDRA HEALTH INC/VA/ quarterly Deferred Income Tax Liabilities, Net in USD history and change rate from 31 Dec 2017 to 30 Jun 2025.
  • ACCENDRA HEALTH INC/VA/ Deferred Income Tax Liabilities, Net for the quarter ending 30 Jun 2025 was $345,000, a 99% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Change (%)

ACCENDRA HEALTH INC/VA/ Quarterly Deferred Income Tax Liabilities, Net (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $345,000 -$28,555,000 -99% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $16,307,000 -$18,130,000 -53% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $19,436,000 -$22,216,000 -53% 31 Dec 2024 10-Q 31 Oct 2025 2025 Q3
Q3 2024 $25,650,000 -$19,966,000 -44% 30 Sep 2024 10-Q 04 Nov 2024 2024 Q3
Q2 2024 $28,900,000 -$26,454,000 -48% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 $34,437,000 -$26,662,000 -44% 31 Mar 2024 10-Q 03 May 2024 2024 Q1
Q4 2023 $41,652,000 -$19,181,000 -32% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 $45,616,000 -$37,857,000 -45% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $55,354,000 -$51,827,000 -48% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $61,099,000 -$49,220,000 -45% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $60,833,000 +$25,523,000 +72% 31 Dec 2022 10-K 20 Feb 2024 2023 FY
Q3 2022 $83,473,000 +$46,380,000 +125% 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 $107,181,000 +$61,854,000 +136% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $110,319,000 +$58,843,000 +114% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $35,310,000 -$15,331,000 -30% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $37,093,000 -$37,916,000 -51% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $45,327,000 +$3,897,000 +9.4% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 $51,476,000 +$8,514,000 +20% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 $50,641,000 +$10,091,000 +25% 31 Dec 2020 10-K 23 Feb 2022 2021 FY
Q3 2020 $75,009,000 30 Sep 2020 10-Q 03 Nov 2020 2020 Q3
Q2 2020 $41,430,000 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $42,962,000 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $40,550,000 -$10,302,000 -20% 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q4 2018 $50,852,000 -$23,395,000 -32% 31 Dec 2018 10-K 04 Mar 2020 2019 FY
Q3 2018 $66,445,000 30 Sep 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 $66,466,000 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q4 2017 $74,247,000 31 Dec 2017 10-Q 05 Nov 2018 2018 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.